comparemela.com
  1. Home
  2. Live Updates
  3. Aptorum Group Or - Breaking News

Latest Breaking News On - Aptorum group or - Page 5 : comparemela.com

Aptorum Group Limited to Hold Annual General Meeting of Shareholders on December 21, 2022

Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) ("Aptorum Group" or "Aptorum"), a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology

City ofUnited kingdomCraig brelsfordHanover squareGhislaine gasparettoAptorum group formAptorum group orInvestor relations departmentSingapore agency for scienceActifin financial communications europeRedchip financial communications united statesDaptorum groupExchange commissionAptorum group limited nasdaqRegulatory newsGroup limited

Aptorum Group Limited: Aptorum Group Updates on Data from the Completed Phase 1 Clinical Trial of SACT-1, targeting neuroblastoma

Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) ("Aptorum Group" or "Aptorum"), a clinical-stage biopharmaceutical company, is pleased to announce the finalized data from

Clark chengGhislaine gasparettoAptorum group formAptorum group orTechnologies pte ltdSingapore agency for scienceActifin financial communications europeRedchip financial communications united statesDaptorum groupAptorum group limited nasdaqRegulatory newsGroup limitedEuronext parisChief medical officerExecutive directorAccelerate technologies pte ltd

Aptorum Group Limited Interview to Air on Bloomberg U S on the RedChip Money Report®

Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum Group” or “Aptorum”), a clinical-stage biopharmaceutical company dedicated to meeting unmet medical needs in

United statesDarren luiAptorum group formDaptorum groupAptorum group orTechnologies pte ltdAptorum group limited nasdaqSingapore agency for scienceRegulatory newsGroup limitedEuronext parisRedchip money reportAccelerate technologies pte ltdAptorum group limitedSecurities litigation reform actFrench autorit

Aptorum Group Limited Interview to Air on Bloomberg U S on the RedChip Money Report

Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) ("Aptorum Group" or "Aptorum"), a clinical-stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology

United statesDarren luiGhislaine gasparettoAptorum group formAptorum group orTechnologies pte ltdInvestor relations departmentSingapore agency for scienceActifin financial communications europeRedchip financial communications united statesDaptorum groupAptorum group limited nasdaqRegulatory newsGroup limitedEuronext parisRedchip money report

Aptorum Group Limited Interview to Air on Bloomberg U S on the RedChip Money Report®

Regulatory News: Aptorum Group Limited , a clinical-stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology and infectious diseases, today announced that an interview. | April 22, 2022

United statesDarren luiAptorum group formDaptorum groupAptorum group orTechnologies pte ltdAptorum group limited nasdaqSingapore agency for scienceRegulatory newsGroup limitedEuronext parisRedchip money reportAccelerate technologies pte ltdAptorum group limitedSecurities litigation reform actFrench autorit

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.